Alan Go to United States Food and Drug Administration
This is a "connection" page, showing publications Alan Go has written about United States Food and Drug Administration.
Connection Strength
0.118
-
Approach to the Postmarket Evaluation of Consumer Wearable Technologies. JAMA Cardiol. 2025 Oct 01; 10(10):1061-1068.
Score: 0.061
-
Influence of Kidney Function Estimation Methods on Eligibility for Edoxaban Population Impact of the US Food and Drug Administration's Approach for Its Product Labeling. Circulation. 2016 10 11; 134(15):1122-1124.
Score: 0.033
-
A protocol for active surveillance of acute myocardial infarction in association with the use of a new antidiabetic pharmaceutical agent. Pharmacoepidemiol Drug Saf. 2012 Jan; 21 Suppl 1:282-90.
Score: 0.024